Existing TERN shareholders should expect shares to become untradeable on public markets, with no further SEC filings for transparency. Any remaining value may be realized through a pending merger consideration or a potential tender offer—monitor for a final distribution or buyout.
Price Chart
Executive Summary
Terns Pharmaceuticals filed a Form 15-12G to terminate its SEC registration under Section 12(g), effective May 15, 2026. The filing reports only one holder of record, following a prior Nasdaq delisting (Form 25-NSE) on May 5, 2026. This completes the company's exit from public reporting, likely due to a going-private transaction or merger, leaving existing shareholders without SEC transparency or exchange liquidity.
Key Facts
- Form 15-12G filed to terminate registration under Section 12(g) of the Securities Exchange Act.
- Only one holder of record as of the certification date.
- Preceded by a Nasdaq delisting filing (Form 25-NSE) on May 5, 2026.
- Company suspends all SEC reporting obligations under Sections 13 and 15(d).
Financial Impact
Complete loss of public market liquidity and transparency; share value likely near zero for remaining public holders.
Risk Factors
- Shareholders may be forced to accept a buyout price below prior market value.
- No ongoing disclosure could mask material adverse changes.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 15-12G Filing (Primary) | 0001193125-26-225474 |
| Document: 0001193125-26-225474-index-headers.html | 0001193125-26-225474 |
| Document: 0001193125-26-225474-index.html | 0001193125-26-225474 |
| Document: 0001193125-26-225474.txt | 0001193125-26-225474 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
May 15, 2026 20w ago | 15-12G | $52.97 awaiting T+1 | awaiting T+1 | — | — |
May 8, 2026 21w ago | EFFECT | $52.95 $52.95 | · 0.00% | ▼ −0.23% | — |
May 5, 2026 21w ago | 8-K | $52.95 $52.95 | · 0.00% | ▼ −1.38% | — |
May 5, 2026 21w ago | 25-NSE | $52.95 $52.95 | · 0.00% | ▲ +1.38% | — |
Apr 27, 2026 22w ago | 8-K | $52.95 $52.94 | ▼ −0.02% | ▲ +0.47% | — |
Apr 27, 2026 22w ago | Press Release | $52.95 $52.94 | ▼ −0.02% | ▲ +0.47% | — |
Mar 25, 2026 27w ago | Press Release | $52.86 $53.17 | ▲ +0.59% | ▲ +2.36% | — |
Feb 28, 2026 30w ago | Institutional Cluster | $42.03 $41.51 | ▼ −1.24% | ▼ −0.32% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access